BlackRock
IBO

BlackRock’s Impact BioMedical IBO Stock Holding History

BlackRock’s Portfolio IBO Stock Details IBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$156K Hold
259,946
– – ﹤0.01% 4854
2025
Q4 		$131K Buy
259,946
+7,216
+3% +$3.82K ﹤0.01% 4833
2025
Q3 		$168K Hold
252,730
– – ﹤0.01% 4716
2025
Q2 		$164K Buy
252,730
+222,055
+724% +$125K ﹤0.01% 4717
2025
Q1 		$26.7K Buy
+30,675
New +$53.1K ﹤0.01% 5042

Other funds holding IBO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM
MAC
Mason & Associates (California) Los Angeles, California $619M AUM 29.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock's IBO Position: Q1 2026 in Review

BlackRock held its Impact BioMedical (IBO) position steady in Q1 2026 at 259,946 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #4854.

BlackRock first reported a position in IBO in Q1 2025 and has held it in 5 quarters since. The position peaked at $168K in Q3 2025. 20 funds tracked by Wall St. Rank hold IBO as of Q1 2026.

  • BlackRock held 259,946 shares of Impact BioMedical worth $156K as of Q1 2026.
  • BlackRock left its Impact BioMedical share count unchanged in Q1 2026.
  • Impact BioMedical made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4854 holding.
  • BlackRock first reported a position in Impact BioMedical in Q1 2025 and has held it in 5 quarters since.
  • BlackRock's Impact BioMedical position peaked at $168K in Q3 2025.
  • 20 funds tracked by Wall St. Rank held Impact BioMedical as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.